Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pediatr.

Sec. Pediatric Oncology

Volume 13 - 2025 | doi: 10.3389/fped.2025.1639582

Pediatric and Young Adult Ovarian Masses: Clinical Approach, Diagnostic Evaluation, and Management

Provisionally accepted
Zeynep  BayramoğluZeynep Bayramoğlu1,2*Buker  TimurBuker Timur1Deniz  KizmazogluDeniz Kizmazoglu3Hikmet  Tunc TimurHikmet Tunc Timur4Oktay  UlusoyOktay Ulusoy5Safiye  AktasSafiye Aktas1,2Nur  OlgunNur Olgun3Sefa  KurtSefa Kurt6
  • 1Dokuz Eylul Unıversty Faculty of Medicine Hospital, Department of Pathology, Izmir, Türkiye
  • 2Department of Molecular Pathology, Dokuz Eylul Universitesi Saglik Bilimleri Enstitusu, Izmir, Türkiye
  • 3Dokuz Eylül University, Division of Pediatric Oncology, Department of Clinical Oncology, Izmir, Türkiye
  • 4Dokuz Eylül University Faculty of Medicine Hospital, Department of Obstetrics and Gynecology, Division of Gynecological Oncology,, Izmir, Türkiye
  • 5Dokuz Eylül University Faculty of Medicine Hospital,Department of Pediatric Surgery, Izmir, Türkiye
  • 6Dokuz Eylül University Faculty of Medicine Hospital, Department of Obstetrics and Gynecology, Division of Gynecological Oncology, Izmir, Türkiye

The final, formatted version of the article will be published soon.

To evaluate the clinical, pathological, and surgical characteristics of ovarian masses in pediatric and young adult patients, with emphasis on malignancy risk, surgical approach, recurrence, and fertility outcomes.This retrospective cohort study included 1,128 female patients under the age of 30 who underwent surgery for ovarian masses between 2003 and 2024. Clinical presentation, imaging, tumor markers, surgical procedures, histopathology, and recurrence were analyzed.The mean age of patients was 13.7 ± 4.02 years. Right-sided masses were more common (69.6%), and 79.9% of surgeries were open. Benign tumors were predominant (most commonly mature cystic teratomas), while dysgerminomas were the most frequent malignant neoplasms. Tumor size was significantly larger in malignant cases (p < 0.005). AFP and β-hCG demonstrated high specificity (88% and 90%, respectively) in predicting malignancy. Fertility-sparing surgery was performed in a large proportion of cases. Recurrence was observed in 31% of borderline tumors, 33% of grade 2-3 immature teratomas, 5% of grade 1 immature teratomas, and 12% of malignant germ cell tumors. Laparoscopic procedures, performed in 20% of patients, were associated with better ovarian preservation. Due to the retrospective design, long-term fertility outcomes were not systematically available.Ovarian masses in pediatric and young adult patients are mostly benign, but a notable risk of malignancy remains, especially in older adolescents and young adults. Tumor markers and imaging aid in preoperative risk stratification. Fertility-sparing surgery is feasible and should be prioritized. However, recurrence rates vary by histology, highlighting the need for structured long-term follow-up in this population.

Keywords: Ovary, Pediactric, Young adolescence, Mass, Maliganant tumor

Received: 02 Jun 2025; Accepted: 17 Aug 2025.

Copyright: © 2025 Bayramoğlu, Timur, Kizmazoglu, Timur, Ulusoy, Aktas, Olgun and Kurt. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Zeynep Bayramoğlu, Dokuz Eylul Unıversty Faculty of Medicine Hospital, Department of Pathology, Izmir, Türkiye

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.